RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
No effect of preoperative ulceration on outcomes of tibiotalocalcaneal arthrodesis
Newton, W., Hoch, C. P., Gross, C. E., & Scott, D. J. (2022). No effect of preoperative ulceration on outcomes of tibiotalocalcaneal arthrodesis. Foot and Ankle Surgery, 28(8), 1235-1238. https://doi.org/10.1016/j.fas.2022.04.004
Background: Tibiotalocalcaneal (TTC) arthrodesis is a commonly performed operation for complex hindfoot pathology, but the effect of preoperative ulceration on TTC outcomes has been debated. This study aims to examine infection rates in patients undergoing TTC arthrodesis with internal fixation with and without concomitant hindfoot ulceration.Methods: We conducted a retrospective review of 31 patients who underwent a TTC arthrodesis between June 2016 and February 2021 with a fellowship-trained foot and ankle surgeon at an academic medical center. Nine (29.0%) patients had preoperative ulceration. Mean follow-up duration was 1.49 (range, 0.51-4.28) years. Other data collected included demographics, comorbidities, surgical approach, fixation method, and complication and reoperation rates. Results: There was no difference in overall complication (ulcer [U]=66.7%, no ulcer [NU]=50.0%; p = .397), infection (U=33.3%, NU=31.8%; p = .935), or reoperation (U=55.6%, NU=27.3%; p = .135) rates between groups.Conclusions: TTC arthrodesis with internal fixation appears to be a reasonable treatment method for pa-tients with a preoperative ulcer. (c) 2022 European Foot and Ankle Society. Published by Elsevier Ltd. All rights reserved.
RTI shares its evidence-based research - through peer-reviewed publications and media - to ensure that it is accessible for others to build on, in line with our mission and scientific standards.